The JAK/STAT signaling pathway: from bench to clinic.
Hu X, Li J, Fu M, Zhao X, Wang W. · 2021
Read The JAK/STAT signaling pathway: from bench to clinic. by Hu X, Li J, Fu M, Zhao X, Wang W. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8617206.txt.
Introduction
Hu and co-authors review the JAK/STAT signaling pathway from basic science to clinic. This pathway sends signals fast from the cell surface to the nucleus. It was found more than twenty-five years ago. It controls key steps in cell growth, cancer, and inflammation.
The review covers the parts of the pathway and how it switches on and off. It then traces what goes wrong in cancer and autoimmune disease. Drugs that block this pathway now treat several of these diseases. The authors weigh the gains and limits of those drugs. Readers get a full tour of a pathway at the heart of many treatments.
Catalog record
| CREATOR | Hu X, Li J, Fu M, Zhao X, Wang W. |
|---|---|
| YEAR | 2021 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 241 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |